CORRECTION article

Front. Immunol., 25 July 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1643932

Correction: Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy

  • 1. College of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China

  • 2. Pharmacy Department, Jinan Huaiyin People’s Hospital, Jinan, China

  • 3. Department of Pharmacy, Shandong Second Provincial General Hospital, Jinan, China

  • 4. Department of Pharmacy, Jinan Licheng District Liubu Town Health Centre, Jinan, China

  • 5. Department of Pharmacy, Jinan Second People’s Hospital, Jinan, China

There was an error in affiliation 3. Instead of “Department of Pharmacy, Shandong University Second People’s Hospital, Jinan, China”, it should be “Department of Pharmacy, Shandong Second Provincial General Hospital, Jinan, China”.

Author “Taijin Shi” was erroneously spelled as “Jintai Shi”.

The Author Contributions Statement has been corrected to read:

“TS: Writing – original draft, Writing – review & editing. XC: Writing – original draft, Writing – review & editing. JW: Supervision, Writing – review & editing. GL: Methodology, Writing – original draft. JM: Validation, Writing – original draft. YZ: Supervision, Writing – original draft, Writing – review & editing.”

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

PC, time, metabolic reprogramming, mechanisms, immunotherapy

Citation

Shi T, Cui X, Wang J, Liu G, Meng J and Zhang Y (2025) Correction: Crosstalk between the tumor immune microenvironment and metabolic reprogramming in pancreatic cancer: new frontiers in immunotherapy. Front. Immunol. 16:1643932. doi: 10.3389/fimmu.2025.1643932

Received

09 June 2025

Accepted

07 July 2025

Published

25 July 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Yingjie Zhang, ; Jiayin Meng,

†These authors share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics